BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 15178736)

  • 1. Amantadine in the akinetic-rigid variant of Huntington's disease.
    Magnet MK; Bonelli RM; Kapfhammer HP
    Ann Pharmacother; 2004; 38(7-8):1194-6. PubMed ID: 15178736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amantadine in Huntington's disease: open-label video-blinded study.
    Lucetti C; Gambaccini G; Bernardini S; Dell'Agnello G; Petrozzi L; Rossi G; Bonuccelli U
    Neurol Sci; 2002 Sep; 23 Suppl 2():S83-4. PubMed ID: 12548355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amantadine in Parkinson's disease: pro and contra.
    Greulich W; Fenger E
    J Neural Transm Suppl; 1995; 46():415-21. PubMed ID: 8821077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term continuous infusion of apomorphine hydrochloride for treatment of Huntington's chorea: A double blind, randomized cross-over trial.
    Vitale C; Marconi S; Di Maio L; De Michele G; Longo K; Bonavita V; Barone P
    Mov Disord; 2007 Dec; 22(16):2359-64. PubMed ID: 17894335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twenty-five years of amantadine therapy in Parkinson's disease.
    Danielczyk W
    J Neural Transm Suppl; 1995; 46():399-405. PubMed ID: 8821075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zotepine in Huntington's disease.
    Bonelli RM; Niederwieser G; Lahousen T; Hofmann P
    Hum Psychopharmacol; 2003 Apr; 18(3):227-9. PubMed ID: 12672176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complex movement behaviour and progression of Huntington's disease.
    Andrich J; Saft C; Ostholt N; Müller T
    Neurosci Lett; 2007 Apr; 416(3):272-4. PubMed ID: 17321683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-dependent improvement of myoclonic hyperkinesia due to Valproic acid in eight Huntington's Disease patients: a case series.
    Saft C; Lauter T; Kraus PH; Przuntek H; Andrich JE
    BMC Neurol; 2006 Feb; 6():11. PubMed ID: 16507108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levodopa responsive parkinsonism in an adult with Huntington's disease.
    Racette BA; Perlmutter JS
    J Neurol Neurosurg Psychiatry; 1998 Oct; 65(4):577-9. PubMed ID: 9771791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between amantadine and the onset of dementia in Parkinson's disease.
    Inzelberg R; Bonuccelli U; Schechtman E; Miniowich A; Strugatsky R; Ceravolo R; Logi C; Rossi C; Klein C; Rabey JM
    Mov Disord; 2006 Sep; 21(9):1375-9. PubMed ID: 16705684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Movement disorder in ataxia-telangiectasia: treatment with amantadine sulfate.
    Nissenkorn A; Hassin-Baer S; Lerman SF; Levi YB; Tzadok M; Ben-Zeev B
    J Child Neurol; 2013 Feb; 28(2):155-60. PubMed ID: 22550086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amantadine in Huntington's chorea.
    Weiner WJ; Klawans HL
    N Engl J Med; 1972 Jan; 286(2):106. PubMed ID: 4256208
    [No Abstract]   [Full Text] [Related]  

  • 13. Visual impairment in Parkinson's disease treated with amantadine: case report and review of the literature.
    Kubo S; Iwatake A; Ebihara N; Murakami A; Hattori N
    Parkinsonism Relat Disord; 2008; 14(2):166-9. PubMed ID: 17509924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amantadine and Huntington's chorea.
    Scotti G; Spinnler H
    N Engl J Med; 1971 Dec; 285(23):1325-6. PubMed ID: 4255886
    [No Abstract]   [Full Text] [Related]  

  • 15. Deleterious effects of minocycline in animal models of Parkinson's disease and Huntington's disease.
    Diguet E; Fernagut PO; Wei X; Du Y; Rouland R; Gross C; Bezard E; Tison F
    Eur J Neurosci; 2004 Jun; 19(12):3266-76. PubMed ID: 15217383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Open-label pilot study of levetiracetam (Keppra) for the treatment of chorea in Huntington's disease.
    Zesiewicz TA; Sullivan KL; Hauser RA; Sanchez-Ramos J
    Mov Disord; 2006 Nov; 21(11):1998-2001. PubMed ID: 16941461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Improvements in motor and non-motor symptoms in parkinson patients under ropinirole therapy].
    Buchwald B; Angersbach D; Jost WH
    Fortschr Neurol Psychiatr; 2007 Apr; 75(4):236-41. PubMed ID: 17427044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of amantadine and haloperidol in Huntington's chorea.
    Saran BM; Klein MS; Benay EM
    J Clin Psychiatry; 1980 Jun; 41(6):221. PubMed ID: 6445900
    [No Abstract]   [Full Text] [Related]  

  • 19. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
    Huot P; Lévesque M; Parent A
    Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Juvenile Huntington's disease: a case report and literature review.
    Reyes Molón L; Yáñez Sáez RM; López-Ibor Alcocer MI
    Actas Esp Psiquiatr; 2010; 38(5):285-94. PubMed ID: 21117003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.